Minireview: Understanding and targeting inflammatory, hemodynamic and injury markers for cardiorenal protection in type 1 diabetes

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

George L. Bakris, Rajiv Agarwal, Stefan D. Anker et al. · New England Journal of Medicine · 2020 · 2.6K citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus

David Z.I. Cherney, Bruce A. Perkins, Nima Soleymanlou et al. · Circulation · 2013 · 1.3K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes

Michael Mauer, Bernard Zinman, Robert Gardiner et al. · New England Journal of Medicine · 2009 · 791 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial

Mark Lakshmanan, Brian Rayner, Robert S. Busch et al. · The Lancet Diabetes & Endocrinology · 2018 · 635 citations

Medicine, Endocrinology, Pharmacotherapy +11

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction

Rudolf A. de Boer, Dirk J. Lok, Tiny Jaarsma et al. · Annals of Medicine · 2010 · 589 citations · Full text

Medicine, Cardiology, Molecular Medicine +17